ucsf banner
Helen Diller Family Compr Cancer Ctr
JOSEPH M. MCCUNE, MD, PHD

Professor of Medicine; Chief, Division of Experimental Medicine; Senior Associate Dean of Clinical and Translational Research, UCSF
Member, UCSF Biomedical Sciences Program (BMS) and Herbert Boyer Program in Biological Sciences (PIBS)

CONTACT

mike.mccune@ucsf.edu
(415) 206-8101 (voice)
(415) 206-8091 (fax)

Box 1234, UCSF; San Francisco, CA 94143-1234

EDUCATION

Harvard College, A.B., 1975, Biochemistry
The Rockefeller University, Ph.D., 1981, Cell Biology/Immunology
Cornell Medical College, M.D., 1982, Medicine

PROFESSIONAL EXPERIENCE

1982-84

Resident in Internal Medicine, University of California, San Francisco

1984-86

Infectious Disease Fellow, University of California, San Francisco

1985-88

Postdoctoral Fellow, Department of Pathology, Stanford University School of Medicine

1987-present

Physician, University of California, AIDS Clinic, San Francisco General Hospital

1988-91

Scientific Director, SyStemix, Inc.

1991-94

Vice-President, New Enterprise Research Division, SyStemix, Inc.

1993-94

Director: SyStemix-Sandoz Antiviral Project & SyStemix-Sandoz HIV Gene Therapy Joint Venture (Progenesys, Inc)

1995-1999

Associate Investigator, Gladstone Institute of Virology and Immunology

1999-present

Senior Investigator, Gladstone Institute of Virology and Immunology

1995-present

Associate Professor of Medicine, University of California, San Francisco

1995-present

Associate Director, General Clinical Research Center, San Francisco General Hospital

2003-2004

Visiting Professor (on sabbatical), Institut Pasteur, Paris, France

HONORS & AWARDS

1972-75

Harvard National Scholarship

1975-76

Michael C. Rockefeller Memorial Fellowship

1986-89

Pfizer Postdoctoral Fellowship in Infectious Diseases

1987

Diplomate, Internal Medicine

1996-2000

Elizabeth Glaser Scientist Award

1999

Member, American Society for Clinical Investigation

2000

Member, American Association of Physicians

2000-2005

Burroughs Wellcome Fund Clinical Scientist Award in Translational Research

2001

NIH MERIT Award

2004

NIH Director's Pioneer Award

SELECTED PUBLICATIONS

(selected from 130)

McCune JM, Humphreys RE, Yocum RR, Strominger JL. Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 72:3206-3209, 1975.

Humphreys RE, McCune JM, Chess L, Herrman HC, Malenka DJ, Mann DL, Parham P, Schlossman SF, Strominger JL. Isolation and immunologic characterization of a human, B-lymphocyte-specific, cell surface antigen. J. Exp. Med. 144: 98-112, 1976.

McCune JM, Lingappa VR, Fu SM, Blobel G, Kunkel HG. Biogenesis of membrane-bound and secreted immunoglobulins. I. Two distinct translational products of human mu chain, with identical N-termini and different C-termini. J. Exp. Med. 152: 463-468, 1980.

McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, and Weissman IL. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 53: 53-67, 1988.

McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, and Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 241: 1632-1639, 1988.

Namikawa R, Kaneshima H, Lieberman M, Weissman IL, and McCune JM. Infection of the SCID-hu mouse by HIV-1. Science. 242: 1684-1686, 1988.

McCune JM, Namikawa R, Shih C-C, Rabin L, and Kaneshima H. Suppression of HIV infection in AZT-treated SCID-hu mice. Science. 247: 564-566, 1990.

Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172: 1055-1063, 1990.

Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H. HIV induces thymus depletion in vivo. Nature. 363: 728-732, 1993.

Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM. HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity. 2: 25-36, 1995.

Jenkins M, Hanley MB, Moreno MB, Wieder E, McCune JM. Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo, Blood. 91: 2672-2678, 1998.

McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. High prevalence of thymic tissue in adults with Human Immunodeficiency Virus-1 infection. J. Clin. Invest. 101 (11): 2301-2308, 1998.

Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA, McCune JM. Restoration of Cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Med. 4: 953-956, 1998.

Berkowitz RD, Beckerman KP, Schall TJ, McCune JM. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J. Immunol. 161: 3702-3710, 1998.

Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med. 5:83-89, 1999.

McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. Factors influencing T-cell turnover in HIV-1-seropositive patients. J. Clin. Invest. 105:R1-R8, 2000.

Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, Herndier BG, Andersson J, McCune JM. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nature Med. 7:73-79, 2001.

Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, 20. McCune JM. Increased thymic mass and circulating naive CD4+ T cells in HIV-1-infected adults treated with growth hormone. AIDS. 16: 1103-1111, 2002.

Keir ME, Stoddart CA, Linquist-Stepps V, Moreno ME, McCune JM. IFN-ƒ¿ secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J. Immunol. 168: 325-331, 2002.

Napolitano LA, Stoddart CA, Hanley MB, Wieder E, McCune JM. Effects of Interleukin-7 on early human thymocyte progenitor cells in vitro and in SCID-hu thy/liv mice. J. Immunol. 171:645-654, 2003.

Hellerstein MK, Hoh RA, Hanley MB, Cesar D, Lee D, Neese RA, McCune JM. Subpopulations of long-lived and short-lived T-cells in advanced HIV-1 infection. J. Clin. Invest. 112: 956-966, 2003

Deeks SG, Martin JN, Sinclair E, Harris J, Neilands T, Maecker HT, Hagos E, Wrin T, Petropoulos CJ, Bredt B, McCune JM. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J. Infect. Dis. 189:312-21, 2004.

Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks S. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol, 79:14169-78, 2005.

Hanley MB, Napolitano LA, McCune JM. Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells, 23:1170-79, 2005.

7/2/07

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.